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Abstract
Rare diseases affect hundreds of millions of people world-
wide but are hard to detect since they have extremely low
prevalence rates (varying from 1/1,000 to 1/200,000 pa-
tients) and are massively underdiagnosed. How do we re-
liably detect rare diseases with such low prevalence rates?
How to further leverage patients with possibly uncertain di-
agnosis to improve detection? In this paper, we propose a
Complementary pattern Augmentation (CONAN) framework
for rare disease detection. CONAN combines ideas from both
adversarial training and max-margin classification. It first
learns self-attentive and hierarchical embedding for patient
pattern characterization. Then, we develop a complementary
generative adversarial networks (GAN) model to generate
candidate positive and negative samples from the uncertain
patients by encouraging a max-margin between classes. In
addition, CONAN has a disease detector that serves as the
discriminator during the adversarial training for identifying
rare diseases. We evaluated CONAN on two disease detection
tasks. For low prevalence inflammatory bowel disease (IBD)
detection, CONAN achieved .96 precision recall area under the
curve (PR-AUC) and 50.1% relative improvement over the
best baseline. For rare disease idiopathic pulmonary fibrosis
(IPF) detection, CONAN achieves .22 PR-AUC with 41.3%
relative improvement over the best baseline.
Introduction
There are more than 7,000 of diseases that are individu-
ally rare but collectively common. These rare diseases af-
fect 350 million people worldwide and incur a huge loss
in quality of life and large financial cost (Vickers 2019).
As these diseases are rare individually, initial misdiagno-
sis is common. On average it can take more than seven
years for rare disease patients to receive the accurate di-
agnosis with the help of 8 physicians (Shire 2013). Thus,
it is important to detect and intervene with the rare dis-
ease before it becomes life-threatening and consumes ex-
cessive medical resources. In recent years, the availability
of massive electronic health records (EHR) data enables
the training of deep learning models for accurate predictive
health (Xiao, Choi, and Sun 2018). However, current success
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mainly focuses on common chronic diseases such as Parkin-
son’s disease progression modeling (Baytas et al. 2017;
Che et al. 2017a) and heart failure prediction (Choi et al.
2018), deep learning models for rare disease prediction are
lacking.
Two key challenges are presented for rare disease detec-
tion. First, the low prevalence rates of rare diseases limit
the number of positive subjects in the training data (i.e., pa-
tients with a confirmed diagnosis of the rare disease). Thus
the disease patterns are hard to extract. Second, there exist
many patients with uncertain diagnosis due to the long pe-
riod needed for rare diseases to be correctly diagnosed. The
existence of large number of such uncertain patients can po-
tentially help the disease detector perform better, as they are
inherently close to positive patients who has confirmed di-
agnosis of the rare disease.
Related setting can be found in Positive-Unlabeled (PU)
learning, which assumes the unlabeled data can contain both
positive and negative examples (Bekker and Davis 2018).
Existing PU learning methods (Elkan and Noto 2008;
Kiryo et al. 2017) often identify reliable negative examples
and then learn based on the labeled positives and reliable
negatives (Liu et al. 2003). However, it is difficult to apply
existing PU learning methods for the rare disease detection
problem as the key difficulty here is to distinguish positive
patients from negative ones with similar conditions. The re-
liable negative examples (e.g., healthy individuals and pa-
tients with similar diseases) will yield a more relaxed clas-
sification hyperplane and thus generate many false positive
cases due to the low prevalence rates of rare diseases.
To mitigate the aforementioned problem, researchers
adopt the generative adversarial networks (GANs) (Good-
fellow et al. 2014) to augment the minor class and balance
the distribution (McLachlan, Dube, and Gallagher 2016;
Choi et al. 2017). However, several challenges are still
present in GAN based methods:
1. They often focus on generating raw patient data, which
is an extremely difficult problem on its own. The result-
ing synthetic data can easily be non-realistic and thus not
useful for disease detection.
2. They often try to augment data based on the rare class
only. However, due to the low prevalence rate, rare class
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(rare disease patients) are insufficient to provide robust
embedding that supports effective data augmentation.
3. Many GAN based methods often generate positive sam-
ples from Gaussian noises and apply a discriminator to
distinguish real from fake data, which is not targeted to-
ward rare disease detection.
To tackle these challenges, we propose pattern augmen-
tation that can better preserve and enrich crucial patterns
of the target disease. We also recognize that among nega-
tive subjects, there exist “borderline” cases that have uncer-
tain diagnoses and potentially have the risk of rare diseases.
For example, a rare disease idiopathic pulmonary fibrosis
(IPF) shares compatible clinical, radiological, and patho-
logical findings with a common chronic disease hypersensi-
tive pneumonitis (Cordeiro, Alfaro, and Freitas 2013). With-
out any further investigation, no definite diagnosis could be
made, leaving many patients to be uncertain.
Based on the above observations, we propose the
Complementary pattern Augmentation (CONAN) framework
which combines the idea of adversarial training and max
margin classification for accurate rare disease detection.
CONAN is enabled by the following technical contributions:
1. Self-attentive and hierarchical embedding for better
patient pattern characterization. CONAN constructs an
end-to-end hierarchical (visit- and patient-level) embed-
ding model with two levels of self-attention to embed the
raw patient EHR into latent pattern vectors. The resulting
patterns can pay more attention to important codes and
visits for each patient (Section. Self-attentive and Hierar-
chical Patient Embedding Net).
2. Disease detection discriminator for improved pattern
classification. Unlike traditional GAN model that uses a
discriminator to classify real or generated data, we con-
struct a disease detector that serves as the discriminator
during the adversarial training for identifying candidate
positive samples by encouraging a max-margin between
the two clusters in the generated complementary samples
(Section. Disease Detector).
3. Complemenrary GAN for boosted pattern augmenta-
tion. CONAN uses an adversarial learning mechanism to
use “uncertain” patients as seeds to generate complemen-
tary patient embedding for boosted pattern augmentation
(Section. Complementary GAN).
We evaluated CONAN on two real-world disease detec-
tion tasks (Section. Experiments). The reported results show
that for low prevalence inflammatory bowel disease detec-
tion, CONAN achieved 50.1% relative improvement in PR-
AUC and 64.5% in F1 over best baseline medGAN. For rare
disease idiopathic pulmonary fibrosis detection, CONAN has
41.3% relative improvement in PR-AUC and 39.3% in F1
over best baseline nnPU. An additional experiment shows
CONAN performs well in early disease detection.
Related Work
Data Augmentation via GAN GAN consists of a gener-
ator that learns to generate new plausible but fake samples
and a discriminator that aims to distinguish generated sam-
ples from real ones. The two networks are set up in minimax
game, where the generator tries to fool the discriminator, and
the discriminator aims to discriminate the generated sam-
ples (Goodfellow et al. 2014). GANs have shown superior
performance in image generation, and also demonstrated ini-
tial success in generating synthetic patient data to address
the data limitation. For example, the medGAN model gener-
ates synthetic EHR data by combining an autoencoder with
GAN (Choi et al. 2017). While the ehrGAN model augments
patient data in a semi-supervised manner (Che et al. 2017b).
However, existing methods use the generator to fake sam-
ples, and once the discriminator is converged, it will not have
high confidence in separating samples.
In this work, we devise a generator which can gener-
ate candidate positive and negative samples, and use them
to enhance classification performances of the discriminator,
rather than distinguishing fake data from real ones.
Deep Phenotyping The availability of massive EHR data
enables training of complex deep learning models for ac-
curate predictive health (Xiao, Choi, and Sun 2018). RE-
TAIN (Choi et al. 2016) uses reverse time attention mech-
anism to detect influential past visits for heart failure pre-
diction. T-LSTM (Baytas et al. 2017) handles irregular time
intervals in the EHR data. Dipole (Ma et al. 2017) embeds
the visits through a bidirectional GRU for diagnosis predic-
tion. MiME (Choi et al. 2018) leverages auxiliary tasks to
improve disease prediction under data insufficiency setting.
Despite these achievements, existing works mainly focus on
common chronic diseases, while deep learning models for
rare disease prediction are lacking.
Positive-Unlabeled Learning In PU learning setting, pos-
itive samples are determined, while unlabeled samples can
either be positive or negative. PU learning has attracted
much attention in text classification (Liu et al. 2003),
biomedical informatics (Claesen et al. 2015) and knowl-
edge based completion (Gala´rraga et al. 2015). Two-step ap-
proaches (Zhou et al. 2004; Fung et al. 2005) first extract re-
liable negative and positive examples and then build the clas-
sifier upon them. Direct approaches (Elkan and Noto 2008;
Sellamanickam, Garg, and Selvaraj 2011; Kiryo et al. 2017)
treat unlabeled examples as negatives examples with class
label noise and build the model directly. However, existing
methods are not suitable for rare disease detection, as men-
tioned in the introduction. In this work, we exploit the un-
certain samples as seeds to generate candidate positive and
negative samples, and build the disease detector by encour-
aging a max-margin between the generated samples.
Method
Task Description
Definition 1 (Patient Records) In longitudinal EHR data,
each patient can be represented as a sequence of multivariate
observations: Pn = {V(t)n }|Pn|t=1 , where n ∈ {1, 2, . . . , N},
N is the total number of patients; |Pn| is the number of vis-
its of the n-th patient. To reduce clutter, we will describe
the algorithms for a single patient and drop the subscript
Table 1: List of basic symbols.
Symbol Definition and description
Pn The EHR data of the n-th patient
Cs, Cp Symptom and procedure code set
c
(t)
i ∈ {0, 1}|C∗| i-th medical code in t-th visit
V(t) Patient’s t-th visit
v(t) Patient’s t-th visit embedding
s(t) Annotation of patient’s t-th visit
u(t) Weight vector
α(t) Normalized weight of t-th visit
h Patient embedding
h+ ∼ pR+(h) Embeddings of positive patients
h− ∼ pR−(h) Embeddings of negative patients
y ∈ {0, 1} Patient’s disease label
F (Pn; θe) Hierarchical embedding networks
D(h; θc) Disease detector
G(h−; θg) Complementary embedding generator
yˆ ∈ {0, 1} Disease prediction of patient
z ∼ pRˆ(h) Generated complementary embedding
n whenever it is unambiguous. For each patient, the visit
V(t) = {c(t)1 , . . . , c(t)|V(t)|} is a set of several symptom and
procedure codes. For simplicity, we use c(t)i to indicate the
unified definition for different type of medical codes; |V(t)|
is the number of medical codes. c(t)i ∈ {0, 1}|C∗| is a multi-
hot vector, where C∗ denotes the symptom code set and the
procedure code set, and |C∗| is the size of the code set.
The patient representation/embedding is denoted as h. As-
sume we have M positive embeddings h+ ∼ pR+(h), and
N −M negative embeddings h− ∼ pR−(h), where R+ and
R− represents the positive samples’ and negative samples’
space respectively. M  N in extremely imbalanced cases.
Table 1 lists notations used throughout the paper.
Problem 1 (Rare Disease Detection) Given each patient
Pn, we want to learn self-attentive and hierarchical patient
embedding net F : F (Pn; θe) → h to get patient embed-
dings which becomes the input with a rare disease detec-
tion function to determine if the patient has rare disease
D : D(h; θc)→ yˆ ∈ {0, 1}.
Problem 2 (Complementary Pattern Augmentation)
Given a set of negative patients’ visit embeddings h−, we
want to learn a generator G that can generate complemen-
tary embeddings: G : G(h−; θg)→ z.
The CONAN Framework
As illustrated in Fig. 1, CONAN includes the following com-
ponents: self-attentive and hierarchical patient embedding
net, complementary GAN, and a disease detector compo-
nent. Next, we will first introduce these modules and then
provide details of training and inference of CONAN.
Self-attentive and Hierarchical Patient Embedding Net
Motivated by previous work (Ma et al. 2017), we leverage
the inherent multilevel structure of EHR data to learn patient
embedding. The hierarchical structure of EHR data begins
with the patient, followed by visits the patient experiences,
then the set of diagnosis codes, procedure, and medication
codes recorded for that visit.
1. Visit Embedding. Given a patient’s visit with codes
V(t) = {c(t)i }|V
(t)|
i=1 , we first embed the codes to vec-
tors via a multi-layer Transformer (Vaswani et al. 2017),
which is a multi-head attention based architecture. It
takes the code embeddings as input and derives code em-
bedding v(t) for a patient at t-th visit. As the medical
codes in one visit is not ordered, it is proper to use Trans-
former as it relies entirely on self-attention to compute
representations of its input and output without using se-
quence aligned RNNs or convolution.
Specifically, we remove the position embedding in the
Transformer, and get the patient representation of t-th
visit is computed as follows:
v(t) = Transformer(V(t)) (1)
2. Patient Embedding. To capture the patient embedding
across multiple hospital visits, we use bidirectional
LSTM (Bi-LSTM) as an encoder. An obvious limitation
of LSTM is that it can only use previous context. The
Bi-LSTM overcomes this gap by incorporating both di-
rections with forward layer and backward layer. To be
specific, given visit embedding v(t) of a patient, the pa-
tient embedding is computed as below.
−→s (t) = LSTM(−→s (t−1), v(t))
←−s (t) = LSTM(←−s (t+1), v(t))
(2)
We obtain an annotation for visit v(t) by concatenating
the forward hidden state −→s (t) and the backward hidden
state ←−s (t), s(t) = [−→s (t),←−s (t)], which summarizes the
information of the all the visits centered around v(t).
In addition, to find out which visit is important in the
whole course, we use self-attention mechanism again to
measure the importance of each visit:
u(t) = u>s tanh(Wss
(t) + bs)
α(t) =
exp(u(t))∑
t exp(u(t))
h =
∑
t
α(t)s(t)
(3)
where u(t) is a hidden representation of s(t) which is ob-
tained by a one-layer MLP and weight vector us, weight
vector us is randomly initialized and learned through the
training process, α(t) is the normalized weight of the t-th
visit, and h is the embedding of a patient which summa-
rizes all the visits and their importance.
The above two-level embedding process of patient’s visits
is denoted as self-attentive and hierarchical patient embed-
ding net h = F (Pn; θe), where θe represents all the param-
eters to be learned for simplicity.
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Figure 1: Framework overview. It contains three main parts: self-attentive and hierarchical patient embedding net, disease
detector and complementary generator. Firstly, we compute the patient’s embedding by Eqn. 1, 2 and 3 through a hierarchical
attention mechanism. Then, we use focal loss to train a disease detector. Finally, we set up a complementary generator (Eqn.
4) to convert negative embeddings to positive with slight modifications, and fine-tune the disease detector with the real and
generated embeddings (Eqn. 7).
Complementary GAN As discussed earlier, some nega-
tive samples can be converted to positive samples (candi-
date positive samples) with slight modifications, while oth-
ers are still negative samples (candidate negative samples).
From an adversarial perspective, the disease detector should
be “smart” enough to classify the candidate positive samples
as positive, and others as negative. We denote the candidate
positive and negative samples generated as “complementary
samples”, and use them to help enhance the performance of
the rare disease detector.
In this section, we introduce a complementary GAN al-
gorithm to generate complementary embedding by using the
negative embeddings z = G(h−; θg) ∼ pRˆ(h), where Rˆ is
the distribution space of the complementary samples. The
learning purpose of the complementary GAN is to balance
the two distribution pR+(h) and pRˆ(h). The generator in-
tends to assign all the generated samples to the positive class
with the disease detectionD(h; θc). Therefore, the loss func-
tion is designed as follows:
Lg(θg) =− λEh−∼pR− [logD(G(h
−; θg); θˆc)]
+ ||G(h−; θg)− h−||2
(4)
where the first term measures the difference between the
output probability and the positive distribution, and the sec-
ond term measures the change between the original negative
samples and the converted samples. λ is a trade-off parame-
ter that controls the relative importance of the two terms. We
tried λ = {0.01, 0.05, 0.1, 0.5, 1} and λ = 0.05 works best.
Disease Detector The disease detector can classify both
generated and original embedding to learn important
codes/visits. It is built on top of the hierarchical embedding,
taking the patient representation h as input. We denote the
disease detector as D(·; θc), where θc represents the param-
eters to be learned. The output of the disease detector is the
probability of this patient being positive.
The goal of the disease detector if to determine whether a
patient has the disease or not. In rare disease detection prob-
lem, the discriminator evaluate 104−105 patients but only a
few have the target rare disease. Such a data imbalance issue
causes two learning problems: (1) the training is insufficient
as the easy negatives do not contain much information; (2)
the easy negatives might degenerate the model. To efficiently
train on all examples, we employ focal loss (Lin et al. 2017):
Lc(θe, θc) = −Eh+∼pR+ [α(1−D(h; θc))γ logD(h; θc)]
− Eh−∼pR− [(1− α)D(h; θc)γ log(1−D(h; θc))] (5)
where γ is a focusing parameter, which focuses more on
hard and easily mis-classified examples, and α is the weight
assigned to the rare class. γ = 2 and α = 0.25 works best
based on the rule of thumb (Lin et al. 2017).
The disease detector is trained as follows. First, the dis-
ease detector works with the embedding net to get pa-
tient representation h. Second, with all the negative sam-
ples that are converted as positive through the generator,
we want the detector to distinguish the candidate positive
samples from the candidate negative samples, through max-
imizing the distance between two classes. Thus, we use
the conditional entropy of labelings (Dai and Hu 2010;
Deng et al. 2017) to maximize the margin:
H(θc) =−D(z; θc) log(D(z; θc))
− (1−D(z; θc)) log(1−D(z; θc)) (6)
So we combine this goal with focal loss to form the final
loss of the detector to further fine-tuning the parameter θc:
Ls(θc) =Lc(θˆe, θc) + ηH(θc) (7)
where η is a weighting factor. We set η = 0.05.
Training and Inference with CONAN
During the training stage, in the first stage, the self-attentive
and hierarchical patient embedding net F (·; θe) work with
disease detector D(·; θc) to minimize the detection loss
Lc(θe, θc), so as to provide insight into which codes and
visits contribute to the rare disease. In the second stage, the
generatorG(·; θg) tries to fool the detectorD(·; θc) by mini-
mizing the loss Lg(θg). Also by minimizing the discrimina-
tion loss Ls(θc), the detector D(·; θc) not only tries to dis-
criminate positive embeddings from negative embeddings,
but also maximize the margin between the two clusters of
generated samples. The detailed training steps are summa-
rized in Algorithm 1.
Algorithm 1: CONAN for Rare Disease Detection.
Input: Training set, training epochs for self-attentive
and hierarchical patient embedding net Ne and
complementary GAN Ng
Output: Well-trained rare disease detector and
complementary patient data embedding z
1 for i = 1, . . . , Ne do
2 Minimize the detection loss Lc(θe, θc) in Eq. 5;
3 end
4 foreach patient in dataset do
5 Compute patient’s embedding h by Eq. 1, 2 and 3;
6 end
7 for i = 1, . . . , Ng do
8 Minimize the generation loss Lg(θg) in Eq. 4 with
negative patient’s embedding h−;
9 Compute the generated samples z;
10 Feed the detector with both the original patient’s
embedding h and generated sample z;
11 Minimize the final detection loss Ls(θc) in Eq. 7;
12 end
Experiments
Experimental Setup
Data We leverage data from IQVIA longitudinal prescrip-
tion (Rx) and medical claims (Dx) databases, which include
hundreds of millions patients clinical records. In our study,
we focus on one rare disease and one low prevalence disease.
1. Idiopathic Pulmonary Fibrosis (IPF) is a pulmonary
disease that is characterized by the formation of scar tis-
sue within the lungs in the absence of any known provoca-
tion (Meltzer and Noble 2008). IPF is a rare disease which
affects approximately 5 million persons worldwide, with
prevalence rate at 0.04%
2. Inflammatory Bowel Disease (IBD) is a broad term that
describes conditions characterized by chronic inflamma-
tion of the gastrointestinal tract. The two most common
inflammatory bowel diseases are ulcerative colitis and
Crohn’s disease. IBD has a low prevalence. Overall, the
prevalence of IBD is 439 cases per 100,000 persons.
For both datasets, we extracted patient records, including
medical/diagnoses/procedure codes at visit level from Jan-
uary 2010 to April 2019, which include total 168,514 dis-
tinct medical codes (ICD-9). Each visit contains patient
id, time of the visit, one symptom code and one diag-
nose/procedure. Data statistics are provided in Table 2.
Baselines We consider the following baseline methods:
• LR: We first embed each code into a vector, then concate-
nate all the vectors together, and feed it to the model.
Table 2: Statistics of datasets. The disease prevalance rates
are the same as case/control ratio in test set.
IPF IBD
Category rare low prevalence
Prevalence 0.04% 0.44%
Positive 9,996 1,405
Negative 24,757,572 108,047
Ave. # of visit 597.36 798.25
• PU-SVM (Elkan and Noto 2008): PU-SVM is a well-
known PU learning model. It labels positive training ex-
amples at random. The data are processed similarly to LR.
• nnPU (Kiryo et al. 2017): A PU learning model that is
more robust against overfitting, and allows for using deep
neural networks given limited positive data. The data are
processed similarly to LR.
• RNN: We feed the code embeddings to a fully-connected
RNN. The output generated by the RNN is directly used
to predict the rare disease.
• T-LSTM (Baytas et al. 2017): T-LSTM handles time ir-
regularity. Similar to RNN, we feed the embeddings to
T-LSTM model, and use the output to predict the disease.
• SMOTE (Chawla et al. 2002): SMOTE is an oversam-
pling method which balances class distribution by ran-
domly increasing minority class examples by replicating
them. We use LR and RNN to generate embeddings, and
then use SMOTE to augment the positive class.
• RETAIN (Choi et al. 2016): RETAIN is a two-level
attention-based neural model which detects influential
past visits and significant clinical variables within those
visits such as key diagnoses. It receives the EHR data in a
reverse time to mimic the practical clinical course.
• medGAN (Choi et al. 2017): medGAN generates syn-
thetic EHR data. We first generate both positive and neg-
ative EHR data to balance the class distribution, and feed
the output of the encoder into an MLP with cross-entropy
loss to predict disease.
• SSL GAN (Yu et al. 2019): SSL GAN can augment pos-
itive embeddings, and facilitate rare disease detection by
leveraging both positive and negative samples.
• Dipole (Ma et al. 2017): Dipole employs bidirectional re-
current neural networks to embed the EHR data. It intro-
duces the attention mechanism to measure the relation-
ships of different visits for the diagnosis prediction.
Metrics To measure the prediction performance, we used
the following three metrics:
1. Area Under the Precision-Recall Curve (PR-AUC):
PR-AUC =
n∑
k=1
Prec(k)∆Rec(k),
where k is the k-th precision and recall operating point
(Prec(k),Rec(k)).
2. F1 Score: F1 Score = 2 · (Prec · Rec)/(Prec + Rec),
where Prec is precision and Rec is recall.
3. Cohen’s Kappa: κ = (po−pe)/(1−pe), where po is the
observed agreement (identical to accuracy), and pe is the
expected agreement, which is probabilities of randomly
seeing each category.
Implementation Details We implement all models with
Keras 1. We sample two imbalanced training sets for each
dataset, with a ratio of 10% and 1% for positive samples.
For the testing set, we extract the data using the actual dis-
ease prevalence rate shown in Table 2. We set 128 for dimen-
sions of patient embedding. For the complementary GAN,
the disease detector serves as the discriminator, and the com-
plementary generator has two hidden layers with 128 di-
mensions. The output layer of the generator has the same
dimension as the patient embedding. The training epoch of
complementary GAN is 1000. For all models, we use RM-
SProp (Hinton, Srivastava, and Swersky 2012) with a mini-
batch of 512 patients, and the training epoch is 30. In order
to have a fair comparison, we use focal loss (with γ = 2
and α = 0.25) and set the output dimension as 128 for all
models. The vocabulary size is consistent with ICD-9 diag-
nosis codes. The sequence length is chosen according to the
average number of visit per patient in Table 2. For RNN and
LSTM, the hidden dimensions of the embedding layer are
set as 128. For other methods, we follow the network archi-
tectures in the papers. All methods are trained on an Ubuntu
16.04 with 128GB memory and Nvidia Tesla P100 GPU.
Results
Performance Comparison For the training data, we tried
positive sample ratios, 10% and 1%, and report better re-
sults of two ratios on IBD and IPF dataset in Table 3. The
best results are presented in bold figures. For IBD, the meth-
ods perform better by using 10% positive samples. For IPF,
the methods perform better with 1% positive samples. We
assume that the method performs best when the ratio of pos-
itive in training data is close to the ratio in test data, which is
the actual prevalence rate of that disease. We also tried 0.1%
and 50% positive on both datasets but did not get satisfying
results. For 0.1% positive, all the samples are classified into
the negative class regardless of the combinations of hyper-
parameters. The medical knowledge about negative patients
suggests us that they can not be strictly counted as a class,
so they contribute little to the identification of positive pa-
tients. For 50% positive, the false positive rate is high on
the test data, which indicates that this training strategy is not
practical for the real-world problem.
From Table 3 we can observe that the performance of LR,
RNN and T-LSTM are less satisfactory, due to the complex-
ity of the disease progression during long clinical courses.
Among the hierarchical embedding methods, RETAIN
and Dipole are two hierarchical embedding methods with
an attention mechanism. We can observe that Dipole per-
forms better than RETAIN. For RETAIN, it models the EHR
data in a reverse time to mimic the practical clinical course.
The recent visits receive greater attention than previous vis-
its. It is not very practical for the rare disease. Due to the
1https://github.com/cuilimeng/CONAN
complexity of the rare disease, the diagnoses/symptoms of
similar diseases may intertwine together during the disease
progression.
Regarding PU learning methods, including PU-SVM and
nnPU, they are designed to exploit the reliable negative cases
in the unlabeled data. However, these methods may not be
suitable for the rare disease detection problem. As the main
challenge in rare disease detection is to distinguish the pa-
tients with the rare disease (e.g., IPF) to patients with simi-
lar diseases (e.g., hypersensitivity pneumonitis), but the de-
tected reliable negative cases are healthy people or patients
with irrelevant diseases, which contribute little to the detec-
tion.
Oversampling (SMOTELR and SMOTERNN ) and gener-
ative (medGAN and SSL GAN) models perform better than
simple sequential models in most cases, which shows the
effectiveness of the data augmentation.
Ablation Study We conduct an ablation study to under-
stand the contribution of each component in CONAN. We re-
move/change the GAN module as below. The parameters in
all the variants are determined with cross-validation, and the
best performances are reported in Table 4.
• w/o GAN: w/o GAN is a variant of CONAN, which only
contains the hierarchical patient embedding net.
• w GAN: w GAN is a variant of CONAN, which replaces
the complementary GAN with the regular GAN, which is
used to augment the positive embeddings.
• w cGAN: this method is CONAN, which incorporates the
complementary GAN.
The results indicate that, when we solely use the self-
attentive and hierarchical patient embedding net, the per-
formances are largely reduced. It suggests the necessity of
data augmentation. When we use the regular GAN to aug-
ment the data, performance are improved but still lower than
CONAN. By augmenting the positive samples, the disease de-
tector will have more confidence in detecting the positive
samples. In other words, it detects more samples as positive,
which yields a much higher false positive rate but doesn’t
decrease the false negative rate much as the ratio of positive
samples is extremely low.
Through the ablation study of CONAN, we conclude that
(1) data augmentation can contribute to the low preva-
lence rate disease detection performance; (2) complemen-
tary GAN is necessary for rare disease detection.
Early Disease Prediction We test how CONAN performs
on early disease prediction for unseen patients. We select
the first x% of visits in each patient’s records for testing,
where x is varied as {100, 50, 20}. Table 5 shows compari-
son results in terms of the PR AUC, F1 Score and Cohen’s
Kappa of early disease prediction. The CONAN achieves a
satisfactory performance when x = 50 and x = 20, and it
is still competitive compared with the baselines. It indicates
that once we train the model, for unseen patients, we can
predict their conditions at an early stage.
Visualize Generated Embedding We project the three
types of patient’s embeddings of IPF dataset, including real
Table 3: Performance Comparison on IPF (rare disease, prevalence rate 0.04%) and IBD (low prevalence disease, preva-
lence rate 0.44% ) datasets. CONAN outperforms all state-of-the-art baselines including GAN based and PU learning baselines.
Dataset Metric LR PU-SVM nnPU RNN T-LSTM SMOTELR SMOTERNN RETAIN Dipole SSL GAN medGAN CONAN
IBD
PR-AUC 0.2765 0.5321 0.5682 0.4373 0.2241 0.3464 0.4471 0.3135 0.5417 0.6072 0.6385 0.9584
F1 Score 0.3651 0.4982 0.4392 0.4332 0.3016 0.4341 0.4642 0.3594 0.5528 0.5416 0.5834 0.9601
Cohen’s Kappa 0.3249 0.5123 0.4624 0.4440 0.2886 0.3451 0.4895 0.3106 0.5904 0.5453 0.4851 0.9595
IPF
PR-AUC 0.0798 0.1141 0.1578 0.0090 0.0084 0.0406 0.0187 0.1016 0.1183 0.0206 0.0954 0.2229
F1 Score 0.1529 0.0915 0.1682 0.0169 0.0211 0.0673 0.0293 0.1345 0.0969 0.0272 0.0729 0.2343
Cohen’s Kappa 0.1369 0.0835 0.1397 0.0261 0.0752 0.0208 0.0429 0.1470 0.1060 0.0372 0.0612 0.2339
Table 4: Abalation study of CONAN demonstrated the advan-
tage of complementary pattern augmentation.
Dataset Metric w/o GAN w GAN CONAN
IBD
PR AUC 0.8097 0.9323 0.9584
F1 Score 0.8386 0.9566 0.9601
Cohen’s Kappa 0.8590 0.9560 0.9595
IPF
PR AUC 0.1796 0.2023 0.2229
F1 Score 0.1119 0.1768 0.2343
Cohen’s Kappa 0.0767 0.1762 0.2339
Table 5: The results on early prediction indicated that we can
use CONAN to predict patients’ conditions at an early stage.
Dataset Metric % Visits in Test Data100% 50% 20%
IBD
PR AUC 0.9584 0.9474 0.7313
F1 Score 0.9601 0.9531 0.7993
Cohen’s Kappa 0.9595 0.9473 0.7629
IPF
PR AUC 0.2229 0.2105 0.0843
F1 Score 0.2343 0.2262 0.1024
Cohen’s Kappa 0.2119 0.2056 0.0758
positive, real negative and generated, to a two-dimensional
space by t-SNE (Maaten and Hinton 2008) and show the pro-
jection in Fig. 2. The red dots indicate the positive embed-
dings. The almond dots indicate the negative embeddings.
The navy dots in four subfigures indicate the samples gener-
ated by regular GAN, medGAN, a PU learning method (Liu
et al. 2003), and CONAN respectively. The generated samples
of the four methods are distributed differently. The samples
generated by regular GAN have the same distribution with
the real positive samples. As a result, it would give the de-
tector more confidence to classify the “borderline” patients
into positive, which may yield a high false positive rate. We
use medGAN to generate both positive and negative cases to
balance the overall class distribution, but the same issue as
regular GAN is still unsolved. The reliable negative samples
generated by the PU learning method span the negative sam-
ples’ space, which contribute little to the rare disease detec-
tion. The complementary samples generated by CONAN lie
in between of real positive and negative samples, which can
help the disease detector update its hyperplane by encourag-
ing a max-margin between the generated samples.
Conclusion
In this paper, we proposed CONAN, a pattern augmenta-
tion method for rare and low prevalence disease detection.
CONAN uses the embedding of negative samples as seeds
(a) Regular GAN (b) medGAN
(c) PU Learning (d) CONAN
Figure 2: 2D visualization of patient embeddings of IPF
dataset: real negative (almond), real positive (red), and gen-
erated (navy). The complementary samples generated by
CONAN lie in between of real positive and negative sam-
ples, which can help the detector update its hyperplane by
encouraging a max margin between the generated samples.
to generate complementary patterns with a complementary
GAN. The generator can convert the negative embedding
to fool the discriminator, while the disease detector serves
as the discriminator to distinguish the positive and nega-
tive samples by maximizing a margin between the generated
samples. After the training, the discriminator can be used
for detecting positive patients. Experiments on real-world
datasets demonstrated the strong performance of CONAN.
The CONAN method can also be extended to other appli-
cation domains for classification problems with imbalanced
data, such as fraud detection and recommendation. Besides,
there are several interesting future directions that need inves-
tigations. First, we can incorporate the data from similar dis-
eases to guide the generation process and obtain more distin-
guishable patient embeddings. Second, other data sources,
such as the doctor notes can be considered for better embed-
ding. Third, time intervals between visits can be considered
for modeling the progression of rare disease.
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Experiment on a Common Disease
We also test the performance of CONAN on a common dis-
ease NASH (Nonalcoholic Steatohepatitis), with prevalence
rate at 7.58%. It is a liver disease that resembles alcoholic
liver disease, but occurs in people who drink little or no alco-
hol. The major feature in NASH is fat in the liver, along with
inflammation and damage. Although the prevalence rate of
this disease is relatively high, but it still occurs an imbal-
anced learning problem when using the data for disease de-
tection. Data statistics are provided in Table 6.
The results are shown in Table 7. Our method still out-
performs the state-of-the-art results 2.56% on PR AUC and
10.10%, which indicates the feasibility of our method. Un-
like rare disease, common disease can often be confirmed by
several symptoms and diagnoses in one visit without misdi-
agnosis. This explains why LR can achieve satisfactory re-
sults. As for CONAN, we remove the position embedding in
the original Transformer while encoding each visit, which
does not enforce the symptoms/diagnoses to be sequential
in each visit.
Table 6: Statistics of NASH dataset. The disease prevalance
rates are the same as case/control ratio in test set.
NASH
Category common
Prevalence 7.58%
Positive 4,380
Negative 57,769
Ave. # of visit 241.47
Table 7: Performance Comparison on NASH dataset.
Method PR-AUC F1 Score Cohen’s Kappa
LR 0.5930 0.5471 0.5380
PU-SVM 0.3971 0.3582 0.3619
nnPU 0.4484 0.3824 0.4139
RNN 0.1841 0.3739 0.4313
T-LSTM 0.3446 0.1783 0.2448
SMOTELR 0.6123 0.5732 0.5842
SMOTERNN 0.2091 0.4195 0.4485
RETAIN 0.5641 0.4627 0.4506
Dipole 0.5929 0.5221 0.5477
SSL GAN 0.5397 0.5340 0.4883
medGAN 0.4825 0.3986 0.3822
CONAN 0.6186 0.6481 0.5958
Data Visualization
We compared the generated patterns of the proposed frame-
work, CONAN, with 3 baseline methods discussed in Sec-
tion. Visualize Generated Embedding, including regular
GAN, medGAN and PU learning method. We first use the
self-attentive and hierarchical patient embedding net to em-
bed the positive and negative samples into vectors with 128
dimensions, then we use t-SNE to project the embeddings
to a two-dimensional space. Finally, we apply the methods
on the embeddings to maintain the consistency and plot the
generated samples. Specifically, we apply each method as
follows:
• Regular GAN: We generate more positive samples.
• medGAN: We generate both positive and negative sam-
ples to balance the overall class distribution.
• PU Learning: We use Biased SVM (Liu et al. 2003) to
generate the reliable negative samples.
• CONAN: We use the complementary GAN in CONAN to
generate the complementary embeddings.
Reproducibility
All codes that we have implemented and adapted, including
CONAN and baselines, are publicly available online2. For the
dataset, we create a sample of the dataset to elaborate the
format of the data used. As for baseline methods, we imple-
mented LP, RNN and SSL GAN by ourselves on Keras. For
other baselines we used the codes provided by the authors.
2https://github.com/cuilimeng/CONAN
